Growth hormone-releasing peptides have become an increasingly important area of focus in modern biochemical research. Among the compounds studied in controlled laboratory environments, CJC-1295 No DAC (also known as Mod GRF 1-29) stands out for its structural properties and the scientific questions it raises around receptor binding, peptide stability, and endocrine system modeling.
Table of Contents
This article provides a neutral, research-focused overview of what this compound is, how CJC-1295 No DAC functions at a molecular level, and why it continues to attract interest in peptide science and analytical laboratory research.
What Is CJC-1295 No DAC?
CJC-1295 No DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH). Unlike its longer-acting counterpart (which includes a Drug Affinity Complex, or DAC), this version lacks the albumin-binding component, resulting in a significantly shorter half-life in biological systems.
It is also referred to as Modified GRF (1-29), based on its structural relationship to the first 29 amino acids of natural GHRH. Researchers use this compound specifically because its shorter activity window more closely mirrors the natural pulsatile pattern of GHRH, making it a useful reference point in experimental models.
Key Structural Features
- Consists of 29 amino acids
- Contains four amino acid substitutions compared to native GHRH (1-29)
- Lacks the DAC component, resulting in faster metabolic clearance
- Binds to the GHRH receptor (GHRHR) with high selectivity
These properties make CJC-1295 No DAC a compound of significant interest for researchers studying receptor kinetics, pulsatile hormone modeling, and peptide degradation pathways.
Mechanism of Action in Research Models
Receptor Binding and Signal Transduction
In laboratory studies, CJC-1295 No DAC interacts with the GHRH receptor located on somatotroph cells. Upon binding, it activates adenylyl cyclase through a G-protein-coupled mechanism, which leads to an increase in cyclic AMP (cAMP) levels. This intracellular signaling cascade is relevant to researchers modeling endocrine pathways.
Because the compound lacks the DAC modification, its receptor interaction is more transient. This creates a sharper, more defined activity curve, which is valuable when researchers need to observe the immediate downstream effects of GHRH receptor stimulation rather than sustained activation.
Half-Life and Metabolic Behavior
One of the most studied characteristics of this compound in vitro is its relatively short half-life, typically estimated at around 30 minutes in biological media. This is a key distinguishing factor from DAC-containing versions, and it plays a significant role in how researchers design their experimental timelines and sampling intervals.
Laboratories exploring peptide stability and degradation often use compounds with predictable half-lives as control reference points. CJC-1295 No DAC fits this profile well, which is why resources dedicated to this compound, such as those listing cjc-1295 no dac for sale for research procurement, emphasize its analytical-grade purity standards.
Research Applications and Scientific Interest
Endocrine System Modeling
Peptide researchers working on growth hormone axis studies frequently incorporate GHRH analogues as tools for understanding feedback loops. CJC-1295 No DAC’s pulsatile behavior is particularly useful for:
- Studying the relationship between GHRH receptor activation and somatostatin inhibition
- Mapping temporal patterns of GH secretion in cell culture models
- Comparing receptor sensitivity across different experimental conditions
Peptide Stability and Formulation Research
Another major research application lies in peptide chemistry and formulation science. Researchers studying how structural modifications affect peptide stability, bioavailability, and receptor selectivity often use Mod GRF 1-29 as a comparative standard.
The four amino acid substitutions in CJC-1295 No DAC were designed to improve resistance to enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV). Understanding these protective mechanisms informs broader research into peptide drug design and metabolic stability optimization.
Analytical Testing and Quality Control
In analytical chemistry contexts, this compound serves as a benchmark for:
- HPLC method development and validation
- Mass spectrometry calibration in peptide quantification studies
- Assessing purity thresholds in synthesized peptide batches
Laboratories sourcing research-grade compounds for these purposes look for strict quality documentation, including certificates of analysis, purity reports, and third-party verification. Databases and repositories that list cjc-1295 no dac for sale in research contexts typically include these documentation standards as part of procurement requirements.
Responsible Research Considerations
Documentation and Reproducibility
Any laboratory working with synthetic peptides must maintain rigorous documentation. This includes:
- Detailed experimental protocols
- Chain-of-custody records for all compounds
- Batch-specific purity data from the supplier
- Clear definitions of intended research use
Reproducibility is a cornerstone of scientific integrity. When peptide compounds are used in experiments, all variables, including compound source, purity percentage, storage conditions, and handling procedures, must be controlled and clearly documented.
Regulatory and Ethical Standards
Research involving peptide compounds must comply with institutional review board (IRB) guidelines and applicable regulatory frameworks. Researchers are expected to:
- Confirm that compounds are used solely for in vitro or preclinical research purposes
- Avoid any use outside a certified laboratory environment
- Follow institutional policies on controlled substance handling and storage
These standards exist to protect research integrity and ensure that scientific findings remain valid, reproducible, and ethically grounded.
Conclusion
CJC-1295 No DAC represents an important compound in peptide research, offering a well-characterized receptor binding profile and predictable metabolic behavior that makes it useful across multiple experimental frameworks. Whether studied for its endocrine modeling applications, its role in peptide stability research, or its utility in analytical method development, this compound continues to generate meaningful scientific inquiry.
The key educational takeaway is this: understanding how structural modifications affect peptide behavior is essential for advancing research in biochemistry, pharmacology, and analytical science. Compounds like Mod GRF 1-29 serve not as ends in themselves, but as tools that help researchers ask better questions about biological systems.
FAQs
1. What does “No DAC” mean in CJC-1295 No DAC?
DAC stands for Drug Affinity Complex, a molecular addition that extends a peptide’s half-life by enabling it to bind to albumin in the bloodstream. “No DAC” means this version lacks that component, giving it a shorter and more naturally pulsatile activity window, which is useful for specific types of receptor kinetics research.
2. How is CJC-1295 No DAC different from native GHRH?
Native GHRH (1-29) is quickly broken down by enzymes like DPP-IV. CJC-1295 No DAC includes four strategic amino acid substitutions that increase its resistance to enzymatic degradation, making it more stable in laboratory conditions while retaining the same core receptor-binding behavior.
3. Why do researchers prefer shorter half-life compounds for some experiments?
Compounds with shorter half-lives allow researchers to observe more discrete, time-limited biological responses. This is particularly valuable when studying pulsatile hormone release patterns, as it avoids receptor desensitization that can occur with prolonged stimulation.
4. What analytical techniques are commonly used to study peptides like this in laboratory settings?
Researchers typically use High-Performance Liquid Chromatography (HPLC), mass spectrometry, and UV absorption spectroscopy to analyze peptide purity, structural integrity, and concentration. These methods are standard in pharmaceutical and biochemical research labs.
5. What documentation should researchers look for when sourcing research-grade peptides?
Researchers should request a Certificate of Analysis (CoA) from the supplier, confirming purity levels (typically greater than 98% for research-grade compounds), batch numbers, testing methodology, and storage recommendations. Third-party independent testing adds an additional layer of verification.
Important Note
All peptides and related compounds mentioned in this article are intended strictly for research and laboratory study purposes only. They are not approved for human use, consumption, or medical application.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN neither agrees nor disagrees with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.
Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything else. The Food and Drug Administration has not evaluated these statements.
Content may be edited for style and length.
References/Sources/Materials provided by:
- National Institutes of Health (NIH) – PubMed: Research literature on GHRH receptor binding and growth hormone secretion models. https://pubmed.ncbi.nlm.nih.gov/
- ScienceDirect – Peptide Science Research Collection: Peer-reviewed studies on synthetic peptide analogues and their structural modifications. https://www.sciencedirect.com/
- National Institute of Standards and Technology (NIST): Guidelines on analytical chemistry standards and peptide quantification methods. https://www.nist.gov/
- OECD Guidelines for the Testing of Chemicals: Internationally recognized frameworks for laboratory testing protocols and experimental reproducibility. https://www.oecd.org/chemicalsafety/testing/
- FDA – Guidance for Industry on Peptide Drug Products: Educational resource on regulatory expectations for peptide-based research compounds and analytical quality standards. https://www.fda.gov/science-research/
